Pharmaceutical Research

, Volume 14, Issue 12, pp 1672–1678 | Cite as

Promoter and Intronic Sequences of the Human Thiopurine S-Methyltransferase (TPMT) Gene Isolated from a Human Pacl Genomic Library

  • Eugene Y. Krynetski
  • Michael Y. Fessing
  • Charles R. Yates
  • Daxi Sun
  • John D. Schuetz
  • William E. Evans
Article

Abstract

Purpose. To isolate and characterize the polymorphic human thiopurine S-methyltransferase (TPMT) gene.

Methods. The human TPMT gene was isolated by PCR screening of a phage artificial chromosome (PAC) library, using exon- and intron-specific primers, then mapped and sequenced.

Results. Two separate PAC1 clones were isolated that contained the same 25 kb gene with 9 exons encompassing the entire TPMT open reading frame. Structural characterization revealed distinct differences when compared to a TPMT gene previously isolated from a chromosome 6-specific human genomic library; the 5′-flanking region (putative promoter) contains 17 additional nucleotides located at position-77 upstream from the transcription start site, in addition to several nucleotide sequence differences, and intron 8 is only 1.6 kb, 5 kb shorter than previously reported. Southern and PCR analyses of genomic DNA from 18 unrelated individuals revealed only the TPMT gene structure corresponding to the PAC clones we isolated. Analysis of the TPMT promoter activity using the 5′-terminal region confirmed transcriptional activity in human HepG2 and CCRF-CEM cells. The 5′-flank is 71% GC rich and does not contain consensus sequences for TATA box or CCAAT elements. FISH analysis demonstrated the presence of the TPMT-homologous sequence on the short arm of chromosome 6 (sublocalized to 6p22).

Conclusions. These findings establish the genomic structure of the human TPMT gene, revealing differences in the promoter and intronic sequences compared to that previously reported and providing a basis for future studies to further elucidate its biological function and regulation.

thiopurine S-methyltransferase gene structure cloning 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    E. Y. Krynetski, H. L. Tai, C. R. Yates, M. Y. Fessing, T. Loennechen, J. D. Schuetz, M. V. Relling, and W. E. Evans. Pharmacogenetics 6:279–290 (1996).Google Scholar
  2. 2.
    R. M. Weinshilboum, and S. L. Sladek. Am. J. Hum. Genet. 32:651–662 (1980).Google Scholar
  3. 3.
    H. L. McLeod, J. S. Lin, E. P. Scott, C. H. Pui, and W. E. Evans. Clin. Pharmacol. Ther. 55:15–20 (1994).Google Scholar
  4. 4.
    L. Lennard, J. S. Lilleyman, J. Van Loon, and R. M. Weinshilboum. Lancet 336:225–229 (1990).Google Scholar
  5. 5.
    L. Lennard, J. A. Van Loon, J. S. Lilleyman, and R. M. Weinshilboum. Clin. Pharmacol. Ther. 41:18–25 (1987).Google Scholar
  6. 6.
    W. E. Evans, M. Horner, Y. Q. Chu, D. Kalwinsky, and W. M. Roberts. J. Pediatr. 119:985–989 (1991).Google Scholar
  7. 7.
    E. Schutz, J. Gummert, F. Mohr, and M. Oellerich. Lancet 341:436 (1993).Google Scholar
  8. 8.
    H. L. McLeod, D. R. Miller, and W. E. Evans. Lancet 341:1151 (1993).Google Scholar
  9. 9.
    L. Lennard, B. E. Gibson, T. Nicole, and J. S. Lilleyman. Arch. Dis. Child 69:577–579 (1993).Google Scholar
  10. 10.
    E. Y. Krynetski, J. D. Schuetz, A. J. Galpin, C. H. Pui, M. V. Relling, and W. E. Evans. Proc. Natl. Acad. Sci. USA 92:949–953 (1995).Google Scholar
  11. 11.
    H. L. Tai, E. Y. Krynetski, C. R. Yates, T. Loennechen, M. Y. Fessing, N. F. Krynetskaia, and W. E. Evans. Am. J. Hum. Genet. 58:694–702 (1996).Google Scholar
  12. 12.
    H. L. Tai, E. Y. Krynetski, E. G. Schuetz, Y. Yanishevski, and W. E. Evans. Proc. Natl. Acad. Sci. USA 94:6444–6449 (1997).Google Scholar
  13. 13.
    C. R. Yates, E. Y. Krynetski, T. Loennechen, M. Y. Fessing, H. L. Tai, C. H. Pui, M. V. Relling, and W. E. Evans. Ann. Int. Med. 126:608–614 (1997).Google Scholar
  14. 14.
    D. Lee, C. Szumlanski, J. Houtman, R. Honchel, K. Rojas, J. Overhauser, E. D. Wieben, and R. M. Weinshilboum. Drug Metab. Dispos. 23:398–405 (1995).Google Scholar
  15. 15.
    C. Szumlanski, D. Otterness, C. Her, D. Lee, B. Brandriff, D. Kelsell, N. Spurr, L. Lennard, E. Wieben, and R. Weinshilboum. DNA Cell Biol. 15:17–30 (1996).Google Scholar
  16. 16.
    P. A. Ioannou, C. T. Amemiya, J. Garnes, P. M. Kroisel, H. Shizuya, C. Chen, M. A. Batzer, and P. J. de Jong. Nat. Genet. 6:84–89 (1994).Google Scholar
  17. 17.
    Genetics Computer Group:Program manual for the GCG Package, version 7. April (1991).Google Scholar
  18. 18.
    R. Honchel, I. A. Aksoy, C. Szumlanski, T. C. Wood, D.M. Otterness, E. D. Wieben, and R. M. Weinshilboum. Mol. Pharmacol. 43:878–887 (1993).Google Scholar
  19. 19.
    P. Senapathy, M. B. Shapiro, and N. L. Harris. Methods Enzymol. 183:252–278 (1990).Google Scholar
  20. 20.
    J. T. Kadonaga, K. A. Jones, and R. Tjian. TIBS 11:20–23 (1986).Google Scholar
  21. 21.
    M. J. Lenardo, and D. Baltimore, Cell 58:227–229 (1989).Google Scholar
  22. 22.
    T. Williams, and R. Tjian. Genes Develop. 5:670–682 (1991).Google Scholar
  23. 23.
    B. Christy, and D. Nathans. Proc. Natl. Acad. Sci. USA 86:8737–8741 (1989).Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Eugene Y. Krynetski
    • 1
    • 2
  • Michael Y. Fessing
    • 1
  • Charles R. Yates
    • 1
  • Daxi Sun
    • 1
    • 2
  • John D. Schuetz
    • 1
    • 2
  • William E. Evans
    • 1
    • 2
  1. 1.Dept. of Pharmaceutical SciencesSt. Jude Children's Research HospitalMemphis
  2. 2.University of TennesseeMemphis

Personalised recommendations